Effects of Pemafibrate on Reducing Oxidative Stress and Augmenting Angiogenesis in Ischemic Limb Tissue
The Kurume Medical Journal · 2022
DOI: 10.2739/kurumemedj.ms6934006 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Kurume Medical Journal, 2022. Verfasst von Tomoyuki Anegawa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Surgery, Department of Surgery, Kurume University School of Medicine. Hauptthemen laut MEDLINE: Oxidative Stress, Benzoxazoles, Ischemia, Neovascularization, Physiologic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Oxidative damage is observed in the ischemic limbs of patients with arteriosclerosis obliterans. We investigated whether pemafibrate, a selective peroxisome proliferator-activated receptor alpha modulator, reduced oxidative stress in ischemic limbs and consequently rescued limb damage in model mice. MATERIALS AND METHODS: We surgically induced hind-limb ischemia in mice and orally administered pemafibrate solution (P-05 group, 0.5 mg/kg/day; P-10 group, 1.0 mg/kg/day) or control solution (control group). Seven days after the surgery, differences in reactive oxygen species (ROS) contents, antioxidative enzyme and transcription factor expression, blood flow, and capillary density in ischemic limbs were assessed. RESULTS: Tissue ROS levels were lower in the P-05 and P-10 groups compared with those in the control group. Although the tissue expression levels of nuclear factor-erythroid 2-related factor 2 increased in the P-10 group compared with that in the control group, no corresponding changes were observed in the tissue expression of four antioxidative enzymes. The limb salvage rates and capillary densities in ischemic limbs were higher in the P-05 and P-10 groups than that in the control group. CONCLUSION: Pemafibrate treatment reduced oxidative stress and augmented angiogenesis in ischemic limbs, contributing to prevention of limb damage in mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Surgery, Department of Surgery, Kurume University School of Medicine.
- Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine.
Zitieren
APA
Anegawa, T., Sasaki, K. I., Ishizaki, Y., Negoto, S., Oryoji, A., Nakamura, E., Otsuka, H., Hiromatsu, S., Fukumoto, Y., & Tayama, E. (2022). Effects of Pemafibrate on Reducing Oxidative Stress and Augmenting Angiogenesis in Ischemic Limb Tissue. The Kurume Medical Journal. https://doi.org/10.2739/kurumemedj.ms6934006
Vancouver
Anegawa T, Sasaki KI, Ishizaki Y, Negoto S, Oryoji A, Nakamura E, et al. Effects of Pemafibrate on Reducing Oxidative Stress and Augmenting Angiogenesis in Ischemic Limb Tissue. The Kurume Medical Journal. 2022. doi:10.2739/kurumemedj.ms6934006
BibTeX
@article{Anegawa2022,
author = {Anegawa, Tomoyuki and Sasaki, Ken-Ichiro and Ishizaki, Yuta and Negoto, Shinya and Oryoji, Atsunobu and Nakamura, Eiji and Otsuka, Hiroyuki and Hiromatsu, Shinichi and Fukumoto, Yoshihiro and Tayama, Eiki},
title = {Effects of Pemafibrate on Reducing Oxidative Stress and Augmenting Angiogenesis in Ischemic Limb Tissue},
journal = {The Kurume Medical Journal},
year = {2022},
doi = {10.2739/kurumemedj.ms6934006}
}
EUVIMED